Blue - you're right about the consolidation in the field. If Healtheon can pay that obscene amount for WebMD, BGIX could indeed theoretically be bought by someone for many times its current price. A couple of days ago, I thought the dramatic drop in HLTH's stock price was signaling the beginning of the end of this mania, but maybe it wasn't. There will be several health website company IPOs in June, including Dr. Koop, which could put a charge into this sector all over again.
You mentioned BGIX's hits. I don't recall seeing the statistics posted anywhere -- do you know what kind of traffic they're getting? Most important to me would be the number of unique users, if the company has disclosed that, rather than just hits. BTW I noted your gracious reference to StayHealthy, which I'm interpreting as something of an olive branch. Please consider it reciprocated. Just FYI, and not to push STAY (there'd be no point, because no one here could buy it until the IPO anyway), STAY's revenues will come primarily from participants in its VitaTrack (body function and body composition analysis and monitoring over the Internet) program, and STAY has already signed a multi-million dollar agreement with a large HMO to provide equipment to the HMO's physicians. Revenues from e-commerce and advertising will be of secondary importance.
You may have noticed that I'm not particularly a fan of BGIX long-term <ggg> (or HLTH, ONHN, MCNS, MCAR or Dr. Koop, for that matter), but I wish you well in your own investment. -Eric |
